These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32663980)

  • 1. Plasma Circular RNA DYM Related to Major Depressive Disorder and Rapid Antidepressant Effect Treated by Visual Cortical Repetitive Transcranial Magnetic Stimulation.
    Song R; Bai Y; Li X; Zhu J; Zhang H; Shi Y; Li K; Wang B; Zhang H; Yang Y; Zhang Z
    J Affect Disord; 2020 Sep; 274():486-493. PubMed ID: 32663980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.
    Hadas I; Sun Y; Lioumis P; Zomorrodi R; Jones B; Voineskos D; Downar J; Fitzgerald PB; Blumberger DM; Daskalakis ZJ
    JAMA Netw Open; 2019 Jun; 2(6):e195578. PubMed ID: 31167023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination.
    Zhang Y; Du L; Bai Y; Han B; He C; Gong L; Huang R; Shen L; Chao J; Liu P; Zhang H; Zhang H; Gu L; Li J; Hu G; Xie C; Zhang Z; Yao H
    Mol Psychiatry; 2020 Jun; 25(6):1175-1190. PubMed ID: 30413800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.
    Oliveira-Maia AJ; Press D; Pascual-Leone A
    Brain Stimul; 2017; 10(4):787-794. PubMed ID: 28438543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive Transcranial Magnetic Stimulation Combined with Antidepressants for the First Episode of Major Depressive Disorder.
    Maneeton B; Maneeton N; Woottiluk P; Likhitsathian S
    Curr Neuropharmacol; 2020; 18(9):852-860. PubMed ID: 32091338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the loudness dependence of auditory evoked potentials with clinical changes to repetitive transcranial magnetic stimulation in patients with depression.
    Lee S; Jang KI; Chae JH
    J Affect Disord; 2018 Oct; 238():451-457. PubMed ID: 29920440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability.
    Chistyakov AV; Kaplan B; Rubichek O; Kreinin I; Koren D; Feinsod M; Klein E
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):223-33. PubMed ID: 15569397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours.
    Yu X; Bai Y; Han B; Ju M; Tang T; Shen L; Li M; Yang L; Zhang Z; Hu G; Chao J; Zhang Y; Yao H
    J Extracell Vesicles; 2022 Jan; 11(1):e12185. PubMed ID: 35029057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control.
    Corlier J; Burnette E; Wilson AC; Lou JJ; Landeros A; Minzenberg MJ; Leuchter AF
    J Affect Disord; 2020 Mar; 265():272-277. PubMed ID: 32090751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor cortical plasticity as a predictor of treatment response to high frequency repetitive transcranial magnetic stimulation (rTMS) for cognitive function in drug-naive patients with major depressive disorder.
    Li X; Yu C; Ding Y; Chen Z; Zhuang W; Liu Z; Fan J; Yan H; Xu W; Zhu G; Zhang X; Zhou D
    J Affect Disord; 2023 Aug; 334():180-186. PubMed ID: 37149052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients.
    Demirtas-Tatlidede A; Mechanic-Hamilton D; Press DZ; Pearlman C; Stern WM; Thall M; Pascual-Leone A
    J Clin Psychiatry; 2008 Jun; 69(6):930-4. PubMed ID: 18505308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis.
    Voigt J; Carpenter L; Leuchter A
    PLoS One; 2017; 12(10):e0186950. PubMed ID: 29073256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease.
    Shin HW; Youn YC; Chung SJ; Sohn YH
    J Neurol; 2016 Jul; 263(7):1442-8. PubMed ID: 27178002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.
    Hunter AM; Nghiem TX; Cook IA; Krantz DE; Minzenberg MJ; Leuchter AF
    Clin EEG Neurosci; 2018 Sep; 49(5):306-315. PubMed ID: 29224411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
    Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
    Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5 Hz Repetitive transcranial magnetic stimulation for posttraumatic stress disorder comorbid with major depressive disorder.
    Carpenter LL; Conelea C; Tyrka AR; Welch ES; Greenberg BD; Price LH; Niedzwiecki M; Yip AG; Barnes J; Philip NS
    J Affect Disord; 2018 Aug; 235():414-420. PubMed ID: 29677606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.